NASDAQ: ABSI

Absci Corp Stock Forecast, Predictions & Price Target

The consensus among 4 Wall Street analysts covering (NASDAQ: ABSI) stock is to Strong Buy ABSI stock.

Out of 4 analysts, 2 (50%) are recommending ABSI as a Strong Buy, 2 (50%) are recommending ABSI as a Buy, 0 (0%) are recommending ABSI as a Hold, 0 (0%) are recommending ABSI as a Sell, and 0 (0%) are recommending ABSI as a Strong Sell.

If you're new to stock investing, here's how to buy Absci stock.

(NASDAQ: ABSI) Absci's forecast annual revenue growth rate of 110.39% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Absci's revenue in 2024 is $5,718,000.On average, 5 Wall Street analysts forecast ABSI's revenue for 2024 to be $1,236,118,953, with the lowest ABSI revenue forecast at $654,150,541, and the highest ABSI revenue forecast at $2,808,335,942. On average, 5 Wall Street analysts forecast ABSI's revenue for 2025 to be $2,715,852,590, with the lowest ABSI revenue forecast at $1,353,414,912, and the highest ABSI revenue forecast at $6,349,771,629.

In 2026, ABSI is forecast to generate $6,911,438,817 in revenue, with the lowest revenue forecast at $5,526,444,224 and the highest revenue forecast at $8,296,433,411.

According to 4 Wall Street analysts that have issued a 1 year ABSI price target, the average ABSI price target is $9.25, with the highest ABSI stock price forecast at $13.00 and the lowest ABSI stock price forecast at $7.00.

On average, Wall Street analysts predict that Absci's share price could reach $9.25 by Mar 26, 2025. The average Absci stock price prediction forecasts a potential upside of 107.63% from the current ABSI share price of $4.46.

(NASDAQ: ABSI) forecast ROE is N/A, which is considered weak.